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Interleukin 20: Discovery, Receptor
Identification, and Role
in Epidermal Function
receptor subunits form a heterodimeric structure similar
to that found in interferon and other class II cytokine
receptors. IL-10 regulates the function of both lymphoid
and myeloid cells, and its immunosuppressive effects
involve inhibition of proinflammatory cytokine synthesis
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Results
Summary Identification, Cloning, and Structural Analysis
of IL-20
A structural, profile-based algorithm was used to iden- EST databases were searched using an algorithm de-
tify interleukin 20 (IL-20), a novel IL-10 homolog. Chro- signed to identify translated sequences containing both
mosomal localization of IL-20 led to the discovery of a signal sequence and one or more amphipathic helices
an IL-10 family cytokine cluster. Overexpression of IL- commonly found in helical cytokines. One of the highest
20 in transgenic (TG) mice causes neonatal lethality scores was from a single EST (INC819592) found in a
with skin abnormalities including aberrant epidermal human keratinocyte library (Incyte Genomics, Inc.).
differentiation. Recombinant IL-20 protein stimulates Based on the EST sequence, nested oligonucleotides
a signal transduction pathway through STAT3 in a ker- were designed and 39 RACE (rapid amplification of cDNA
atinocyte cell line, demonstrating a direct action of ends) was performed on RNA isolated from human skin
this ligand. An IL-20 receptor was identified as a heter- and trachea, yielding the remainder of the coding se-
odimer of two orphan class II cytokine receptor sub- quence, 39 untranslated region (UTR) and polyadenyla-
units. Both receptor subunits are expressed in skin tion sequence. The 39 UTR of this cDNA contains seven
and are dramatically upregulated in psoriatic skin. AUUUA and one perfect UUAUUUAUU mRNA instability
Taken together, these results demonstrate a role in motifs (Zubiaga et al., 1995) often found in cytokine
epidermal function and psoriasis for IL-20, a novel mRNAs, which may explain its rarity in EST databases.
cytokine identified solely by bioinformatics analysis. Northern analysis indicates that this mRNA is expressed
at very low levels in skin, trachea and in other tissues
(data not shown).Introduction
Analysis of the entire coding sequence not only sup-
ports the classification of this protein as a helical cyto-We describe the use of EST database mining in the
discovery of interleukin-20 (IL-20), a novel IL-10-related kine, but also indicates that it is a member of the IL-10
family. This novel cytokine was named interleukin 20 (IL-cytokine. The IL-10 protein family includes IL-10 (Vieira
et al., 1991), IL-19 (Rosen and Kenny, 1999), MDA-7 20). Figure 1A shows a sequence comparison between
human IL-20 and its three closest relatives based on(Jiang et al., 1995), IL-TIF (Dumoutier et al., 2000a), and
AK-155 (Knappe et al., 2000). The biological function of amino acid sequence identity: IL-19 (40%), MDA-7
(33%), and IL-10 (28%). IL-20 also shares sequenceIL-10 itself has been explored in depth. IL-10 mediates
its activity through a receptor which is composed of IL- identity with two other IL-10 family members, IL-TIF
(25%) and AK-155 (24%). Mouse IL-20 cDNA was iso-10Ra and IL-10Rb (CRF2-4; Kotenko et al., 1997). These
lated from a mouse skin library using a human IL-20
coding region probe. Both human and mouse IL-20 con-7 To whom correspondence should be addressed (e-mail: chandray@
tain 176 amino acids and are 76% identical in aminozgi.com).
8 These authors contributed equally to this article. acid sequence.
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Figure 1. Multiple Alignment and Chromo-
somal Mapping of the IL-10 Protein Family
(A) Sequence of human IL-20 and its align-
ment with three other human members of the
IL-10 protein family. Asterisks denote con-
served residues, colons represent highly con-
served residues, dots represent conservative
substitutions, the arrow indicates the experi-
mentally determined signal sequence cleav-
age site of IL-20, and underlines show the
helical regions of IL-10. The location of con-
served cysteines is indicated in bold type. (B)
Chromosomal mapping of IL-20. IL-20 maps
to human chromosome 1q32 and is tightly
linked to IL-10, IL-19 and MDA-7.
IL-20 and IL-19 contain six conserved cysteine resi- mouse IL-20 showed that it maps to the syntenic region
on mouse chromosome 1. Since IL-10 maps to the samedues in their mature protein sequence, in contrast to IL-
10, which only has four. Protein crystallographic analysis region (Eskdale et al., 1997), we mapped the other four
IL-10 family members. MDA-7 and IL-19 also map toof IL-10 indicates that it forms an intercalating dimer
(Zdanov et al., 1995). Threading the IL-20 sequence onto chromosome 1q32 (Figure 1B) whereas AK-155 and IL-
TIF do not (Knappe et al., 2000 and data not shown).the human IL-10 structure yielded predictions about the
cysteine pairing and oligomerization of IL-20. By analogy More detailed analysis using P1 artificial chromosome
(PAC) clones allowed us to deduce the gene order onwith the two disulfide bonds in IL-10, the pairings Cys33-
Cys126, and Cys80-Cys132 in IL-20 can be inferred. chromosome 1 as IL-10, IL-19, IL-20, MDA-7 and to
localize these genes within a 195 kb region (Figure 1B).However, residues Gln81 and Asn134 in IL-10, corre-
sponding to Cys81 and Cys134 in IL-20, have a separa- These mapping studies indicate that four members of
the IL-10 family comprise a cytokine cluster.tion of 11.6 A˚. IL-10, which forms an intercalating dimer,
contains Asn116 in a potential flexible hinge region be-
tween the core of one monomer and the helix contrib- IL-20 Transgenic Mice Exhibit Aberrant Keratin
Expression in Skinuted by the other monomer. If Cys81 and Cys134 in IL-
20 were disulfide bonded, the hinge region would be Both human and mouse IL-20 were overexpressed in
TG mice using a variety of promoters. The liver-specificbrought into close contact with the amino-terminus of
helix B, leading to the prediction that IL-20 does not mouse albumin (ALB) promoter (Pinkert et al., 1987),
directing expression of human IL-20, was used initiallyform an intercalating dimer. Analysis of recombinant
human IL-20 produced in BHK and in baculovirus cells in an attempt to achieve circulating levels of protein.
Subsequent studies were conducted using the keratinsupports this prediction.
14 (K14) promoter (Vassar and Fuchs, 1989), which pri-
marily targets expression to the epithelium; the mouseIL-20 Maps to a Cytokine Cluster
Radiation hybrid mapping was used to map IL-20 to metallothionein-1 (MT-1) promoter (Palmiter et al., 1993),
which gives a broad expression pattern; and the EmLCKhuman chromosome 1q32. Chromosomal localization of
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Figure 2. Skin Phenotype in IL-20 Transgenic
Mice
(A) Shiny, wrinkled skin and smaller size in
the IL-20 TG pup (bottom) compared to age-
matched NTG littermate (top). (B) H&E-
stained skin section (403) from a 1-day-old
NTG control mouse. SC 5 stratum corneum,
SS 5 stratum spinosum. (C) Electron micro-
graph (EM) of the skin from a 1-day-old NTG
mouse (16,0003). Note that the keratohyaline
granules (white asterisk) are electron-dense.
(D) H&E-stained skin section from a 1-day-
old TG mouse with the ALB promoter driving
mouse IL-20 (403). The SC is more compact
and the SS is thicker than in the age-matched
control. (E) EM from a 1-day-old TG mouse
with the ALB promoter driving human IL-20
(16,0003). The keratohyaline granules (white
asterisk) are moth-eaten and scattered mito-
chondria (arrow) contain lipoid inclusions.
promoter (Iritani et al., 1997), which drives expression human psoriatic skin were not observed in the IL-20
TG mouse skin. In addition, many of the TG mice hadin cells of the lymphoid lineage. Similar results were
obtained in all four cases, possibly because these pro- apoptotic thymic lymphocytes (data not shown). No
other abnormalities were detected by histopathologicalmoters all give rise to circulating IL-20.
In all cases, TG pups expressing the IL-20 transgene analysis. These histological and EM results support and
extend the observed gross skin alterations.were smaller than non-TG (NTG) littermates, had a shiny
appearance with tight, wrinkled skin, and died within Immunohistochemical analysis of epidermal markers
was utilized to determine whether normal skin differenti-the first few days after birth (Figure 2A). Pups had milk in
their stomachs indicating that they were able to suckle. ation had taken place in the TG mice. These studies
were performed on TG mice expressing IL-20 from theThese mice had swollen extremities, tail, nostril, and
mouth regions and had difficulty moving. In addition, K14 promoter. Positive staining for K5 and K14 was
detected in the suprabasal layer of the epidermis inthe mice were frail, lacked visible adipose tissue and
had delayed ear and toe development. Low expression addition to the expected basal layer, while staining for
the hyperproliferation marker K6 in the suprabasal layerlevels in liver (less than 100 mRNA molecules/cell) were
sufficient for both the neonatal lethality and skin abnor- was detected in TG but not in NTG littermate skin (Figure
3). In contrast, the staining pattern for K1 (suprabasal),malities. TG mice without a visible phenotype either did
not express the transgene, did not express it at detect- filaggrin (granular), and loricrin (upper spinous, granular)
did not differ in the two groups of mice (Figure 3 andable levels, or were mosaic.
Histologic analysis of the skin of the IL-20 TG mice data not shown). Similar immunohistochemical results
were obtained in TG mice expressing IL-20 from the ALBshowed a thickened epidermis, hyperkeratosis and a
compact stratum corneum compared to NTG littermates promoter (data not shown). Therefore, overexpression of
IL-20 in TG mice results in aberrant expression of several(Figures 2B and 2D). Serocellular crusts (scabs) were
observed occasionally. Electron microscopic (EM) anal- keratins indicative of altered epidermal differentiation.
IL-20 TG mouse skin has a thickened epidermis andysis of skin from TG mice showed intramitochondrial
lipoid inclusions, mottled keratohyaline granules, and expresses K6, both suggestive of hyperproliferation. To
assay directly for hyperproliferation, PCNA immunohis-relatively few tonofilaments (Figures 2C and 2E) similar
to that observed in human psoriatic skin (Gijbels et al., tochemical staining was performed on skin from TG
mice expressing IL-20 from the ALB and K14 promoters,1995). However, immune infiltrates commonly found in
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IL-10Ra, IL-10Rb (CRF2-4), interferon-aR1, interferon-
aR2, interferon-gR1, and three orphan receptors zcy-
tor7, zcytor11 (reported to be an IL-TIF receptor subunit;
Xie et al., 2000), and DIRS1 (Parham et al., 1999). Candi-
date class II receptors were selected based on their
expression in the human keratinocyte cell line HaCaT,
previously determined to be responsive to IL-20. These
receptors were transiently expressed in COS7 cells,
which were then assayed for their ability to bind biotin-
labeled IL-20 protein. None of the single receptor
transfectants had detectable IL-20 binding. Only one
pairwise combination of receptor subunits, zcytor7 (des-
ignated IL-20Ra) and DIRS1 (designated IL-20Rb), gave
rise to transfectants with positive IL-20 binding. There-
fore, these proteins comprise a heterodimeric IL-20 re-
ceptor, structurally similar to the IL-10 receptor.
The specificity and affinity of IL-20 for its receptor
was determined using BHK cells stably transfected with
IL-20Ra, IL-20Rb or both receptor subunits. Binding
assays using radiolabeled ligand demonstrated that IL-
20 bound to BHK transfectants expressing both IL-20Ra
and IL-20Rb, but not to untransfected cells nor to
transfectants expressing either receptor subunit alone
(Figure 4A). Binding of 125I-labeled IL-20 was eliminated
in the presence of 100-fold excess of unlabeled IL-20 but
not in the presence of 100-fold excess of the unrelated
cytokine, IL-21 (HUGO symbol for zalpha11 ligand; No-
vak et al., 2000). The binding data revealed 88,000 IL-
20 receptors per cell with a binding affinity (Kd) of z1.5
nM (Figure 4B).
IL-20 Binding Activates STAT3 in the HaCaT
Keratinocyte Cell Line
As shown above, IL-20 binds cell lines transfected with
both subunits of its receptor. However, these cell lines
overexpress the IL-20 receptor relative to its normal
level and their relevance to the physiological role of IL-
20 is unclear. The human HaCaT keratinocyte cell line,
which expresses endogenous IL-20Ra and IL-20Rb, was
used to examine IL-20 signal transduction in a biologi-Figure 3. Aberrant Expression of Keratin Proteins Demonstrated by
cally relevant cell type. HaCaT cells were infected withImmunohistochemical Analysis
recombinant adenovirus containing a reporter constructK5 and K14 were detected in the basal layer of the epidermis in
to allow detection of intracellular signaling. The con-NTG mice. Similar sections obtained from TG mice derived from
mouse IL-20 expressed from the K14 promoter show positive stain- struct consists of the firefly luciferase gene driven by
ing in the suprabasal layer of the epidermis as well. Also shown is promoter/enhancer sequences comprised of the serum
positive staining for K6 in the suprabasal layer in TG mouse skin response element (SRE) and signal transducers and ac-
but not in NTG mouse skin. Filaggrin (Fil) staining was similar for
tivators of transduction elements (STATs). This assayboth TG and NTG mouse skin (203).
system detects productive ligand-receptor interactions
and indicates possible downstream signal transduction
components involved in receptor activation. Treatmentand from their NTG littermates. Staining in the basal skin
layer was observed in NTG mice as expected, since this with IL-20 alone resulted in a dose-dependent increase
in luciferase activity with a half-maximal response oc-is the skin layer where proliferation normally takes place.
However, in TG mouse skin, PCNA staining was ob- curring at z2.3 nM (Figure 5A). Subsequent luciferase
reporter assays using adenovirus vectors containing onlyserved in both the basal and suprabasal layers of the
epidermis (data not shown). We conclude that hyper- the SRE element or only the STAT elements produced
detectable reporter activation only through STATs (dataproliferation occurs in the skin of IL-20 TG mice.
not shown).
To determine if other cytokines act in concert withIdentification of a Heterodimeric IL-20 Receptor
Because IL-20 is homologous to IL-10, we hypothesized IL-20, HaCaT cells were treated with IL-20 alone or in
combination with a single submaximal dose of EGF, IL-that the IL-20 receptor might share structural similarity
with the heterodimeric IL-10 receptor. Therefore, we 1b, or TNFa. These three proteins were chosen based
on a screen of twelve cytokines and growth factors fortested eight different class II cytokine receptors alone
or in pairwise combinations in an IL-20 binding assay: activation of luciferase reporter constructs. Robust re-
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BHK cells, as compared to HaCaT cells, due to higher
receptor levels in the BHK IL-20 receptor transfectants.
It is well established that ligand binding to class II
cytokine receptors, such as IL-10R, leads to activation
of JAK kinases, phosphorylation of STATs and their sub-
sequent translocation into the nucleus, where they acti-
vate transcription of target genes. A nuclear transloca-
tion assay was used to identify STAT proteins involved
in IL-20 action. Both HaCaT cells, with endogenous IL-
20 receptors, and BHK cells transfected with IL-20Ra
and IL-20Rb were treated with IL-20 protein, and translo-
cation of STAT3 and STAT1 transcription factors from
the cytoplasm to the nucleus was assayed by immuno-
fluorescence.
In unstimulated HaCaT cells, STAT3 staining was pre-
dominantly in the cytosol (Figure 5C). Treatment of Ha-
CaT cells with IL-20 resulted in a distinct accumulation
of STAT3 in the nucleus (Figure 5D). In contrast to STAT3
translocation, HaCaT cells treated with IL-20 did not
show any detectable nuclear accumulation of STAT1
(data not shown).
BHK cells transfected with IL-20Ra and IL-20Rb were
used to confirm that the IL-20 receptor was required for
IL-20 stimulation of STAT3 nuclear translocation. In BHK
cells lacking the IL-20 receptor, STAT3 remained cyto-
solic following treatment with IL-20 (Figure 5E). In con-
trast, in BHK cells transfected with the IL-20 receptor,
STAT3 translocated to the nucleus in response to IL-20Figure 4. IL-20 Binds to the IL-20 Heterodimeric Receptor
(Figure 5F). Again, STAT1 remained cytosolic regardless(A) 125I-IL-20 binds to transfected BHK cells expressing IL-20Ra and
IL220Rb (solid bars), and is blocked by a 100-fold excess of IL- of IL-20 treatment or IL-20 receptor expression (data
20 but not by IL-21. In contrast, 125I-IL-20 does not bind to non- not shown). We conclude that the IL-20 receptor is re-
transfected BHK cells (open bars), to transfected BHK cells express- quired for IL-20-mediated STAT3 activation.
ing IL-20Rb alone (cross-hatched bars) or to IL-20Ra alone (tiled To screen for potential downstream target genes forbars). (B) Saturation curve for binding of 125I-IL-20 to transfected
IL-20 activity, microarray analysis was performed onBHK cells expressing IL-20Ra and IL-20Rb. The curves represent
mRNA isolated from HaCaT cells treated with IL-20,total binding (solid squares); nonspecific binding in the presence of
100-fold excess unlabeled IL-20 (solid circles); and specific binding IL-1, or IL-20 plus IL-1. Human cytokine, growth factor,
determined by subtraction of nonspecific from total binding (solid and receptor genes were represented on the microarray.
triangles). A Scatchard transformation of the specific binding data Expression of a number of genes increased 2- to 4-fold
is shown in the insert. in response to IL-20 alone. In addition, a different, but
overlapping, set of genes had higher expression in re-
sponse to IL-20 1 IL-1 than the sum of the individualsponses were observed with EGF, IL-1b, TNF-a, and
cytokine responses (Experimental Procedures). A highTGF-a, while KGF gave a response similar in magnitude
percentage of these genes are involved in inflammation.to IL-20. The other seven cytokines, including IL-10,
RT-PCR analysis on three of these genes, TNF-a, MRP-14,were inactive in this assay. In the presence of EGF,
and MCP-1, confirmed these results (data not shown).IL-1b, or TNF-a, IL-20 treatment resulted in a dose-
We conclude that the magnitude of specific target genedependent increase in luciferase activity (Figure 5A and
expression based on microarray and RT-PCR resultsdata not shown). IL-20 in combination with IL-1b results
correlated with those of reporter gene activation in Ha-in a half-maximal response at z0.5 nM, about 5-fold
CaT cells. IL-20 alone exhibited a modest increase inlower than with IL-20 alone. In addition, activation of
specific target gene expression and showed enhance-the reporter gene is detectable at 0.1 nM IL-20, a dose
ment of the IL-1-induced expression of at least threethat is at least 10-fold lower than the IL-20 dose required
genes known to be involved in inflammatory responses.alone.
BHK cells transfected with IL-20Ra, IL-20Rb, or both
receptor subunits were used to determine whether re- Expression of IL-20Ra and IL-20Rb in Skin
and Upregulation in Psoriasisceptor pairing was required for IL-20 stimulation of
STAT-luciferase. As was the case with binding assays, The expression pattern of IL-20Ra and IL-20Rb in a
variety of human tissues was determined by RT-PCRonly cells transfected with both receptor subunits re-
sponded to IL-20 and did so with a half-maximal re- analysis. Both IL-20Ra and IL-20Rb are most highly ex-
pressed in normal skin and testis, with lower expressionsponse of 5.7 pM (Figure 5B). We note that the IL-20
concentration for the half-maximal response in BHK in a variety of other normal tissues (Figure 6). In addition,
IL-20Ra mRNA appears to be expressed in many tissuecells is 400-fold lower than that for half-maximal re-
sponse in HaCaT cells. It is likely that a lower concentra- types where IL-20Rb expression is undetectable under
similar conditions. Most significant for the present studytion of IL-20 is needed for half-maximal response in
Cell
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Figure 5. IL-20 Stimulates a Signal Trans-
duction Pathway through STAT3
Panels (A) and (B) utilize luciferase reporter
constructs to detect intracellular signaling.
(A) HaCaT cells were infected with an adeno-
virus construct containing SRE and STAT
promoter elements driving expression of lu-
ciferase. Treatment of HaCaT cells with IL-20
alone results in a dose-dependent increase
in luciferase activity, which is dramatically en-
hanced by the addition of 0.1 nM IL-1b. (B)
BHK cells were stably transfected with STAT
promoter elements driving expression of lu-
ciferase. Treatment of BHK cells expressing
IL-20Ra and IL-20Rb with IL-20 results in a
dose-dependent increase in luciferase activity.
Panels (C)–(F) assay the translocation of STAT3
transcription factor from the cytoplasm to the
nucleus by immunofluorescence. STAT3 stain-
ing was predominantly in the cytosol in un-
stimulated HaCaT cells (C), whereas treat-
ment of HaCaT cells with IL-20 resulted in a
distinct nuclear accumulation of STAT3 (D).
BHK cells lacking the IL-20 receptor had cyto-
solic STAT3 following treatment with IL-20
(E), whereas BHK cells transfected with IL-
20Ra and IL-20Rb, had STAT3 translocation
to the nucleus in response to IL-20 (F).
is that IL-20Ra and IL-20Rb are both expressed in skin, able levels of either receptor subunit mRNA (Figures
7A–7F). The difference between these in situ hybridiza-where they are involved in IL-20 binding and activation
of signal transduction. tion results and the RT-PCR results described above
for normal skin may reflect the higher sensitivity of theWe hypothesized that the IL-20 receptor may have
altered regulation in skin diseases. To test this hypothe- RT-PCR assay. In some of the psoriatic skin samples,
positive signals were also observed for both IL-20 recep-sis, in situ hybridization was performed on skin samples
from seven psoriasis patients and three patients with tor subunits in mononuclear immune cells and in endo-
thelial cells in a subset of vessels (Figures 7G and 7H).normal skin. All seven psoriatic skin samples had high
levels of IL-20Ra and IL-20Rb mRNA in keratinocytes Therefore, both IL-20Ra and IL-20Rb are expressed in
keratinocytes, immune cells, and endothelial cells, thewhereas normal skin samples had minimal to undetect-
Discovery of IL-20 and Its Heterodimeric Receptor
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Figure 6. Expression of IL-20Ra and IL-20Rb
in Human Tissues
RT-PCR analysis of IL-20Ra and IL-20Rb was
performed using a panel of 24 human tissues.
Both receptor subunit mRNAs are highly ex-
pressed in skin and testis.
major cell types thought to interact in psoriasis (Bos units in the four other known class II cytokine receptors
(Domanski and Colamonici, 1996; Pestka et al., 1997;and De Rie, 1999; Karasek, 1999).
Xie et al., 2000). For example, in the IL-10 heterodimeric
receptor, the IL-10Ra subunit is sufficient for high-affin-Discussion
ity ligand binding, while IL-10Rb is required for signaling
(Kotenko et al., 1997). IL-20Ra and IL-20Rb are alsoIL-20 stimulates signal transduction in the human kera-
tinocyte HaCaT cell line, supporting a direct action of coexpressed in a number of human tissues besides skin,
suggesting additional target tissues for IL-20 action.this novel ligand in skin. In addition, IL-1b, EGF, and
TNF-a, proteins known to be active in keratinocytes and Additionally, we have detected IL-20Ra mRNA, but not
IL-20Rb mRNA, in several human tissues suggestingto be involved with proliferative and proinflammatory
signals in skin, enhance the response to IL-20. IL-20 that IL-20Ra may partner with other class II receptor
subunits. However, unlike the class I cytokine receptormay be a cytokine that exhibits its most potent effects
in combination with other factors, similar to the role that common signaling subunits bc, gp130, and IL2Rg, there
is only one example of a shared receptor subunitstem cell factor and flt-3 ligand play in the hematopoietic
system (Koller et al., 1996). In both HaCaT and BHK cells (CRF2-4) in the class II receptor family (Dumoutier et al.,
2000b; Xie et al., 2000). It is also possible that theexpressing the IL-20 receptor, IL-20 signals through
STAT3 as does IL-10 (Kotenko and Pestka, 2000). IL-10 IL20Ra/IL20Rb heterodimeric receptor acts as a recep-
tor for other IL-10 family members. We conclude thatalso activates STAT1 to some extent, which was not
observed for IL-20. Future experiments will be directed the IL-20 heterodimeric receptor is structurally similar
to other class II cytokine receptors and is expressed inat defining additional components of the IL-20 signal
transduction pathway and at understanding the role of skin where we have demonstrated activity of the IL-20
ligand.its inflammation-related target genes.
Colocalization of IL-20 with three other IL-10 family Two lines of evidence suggest a role for IL-20 and its
receptor in psoriasis. This multigenic skin disease ismembers identifies the 1q32 region as a cluster of cyto-
kine genes. Clustering of family members may be the characterized by increased keratinocyte proliferation,
altered keratinocyte differentiation, and infiltration of im-result of gene duplication with subsequent divergence
of function and regulation. The known activities for the mune cells into the skin (Bos and De Rie, 1999). The
first line of evidence for a role of IL-20 in psoriasis isIL-10 family members in this cluster reflect this func-
tional divergence. IL-10 has anti-inflammatory activity that the observed hyperkeratosis, thickened epidermis,
and proliferation in the suprabasal layer in the TG micein skin due to inhibition of proinflammatory cytokine
synthesis. Consistent with this observation, expression that resemble human psoriatic abnormalities. Changes
detected in the epidermal protein expression in IL-20of both IL-10 and the IL-10 receptor are decreased in
psoriatic skin (Michel et al., 1997; Asadullah et al., 1998). TG mice include the presence of the basal K5 and K14
in both the basal and suprabasal layers, similar to theIn contrast, expression of both IL-20 receptor subunits
is increased in psoriatic skin. MDA-7 expression is ele- changes observed in human psoriatic skin (Sun et al.,
1985; Castelijns et al., 1999). IL-20 TG mice also expressvated in melanoma cells and is thought to have antitu-
mor activity (Jiang et al., 1996), while the actions of IL- the hyperproliferative-associated K6, present in human
psoriatic but not normal skin. Similar skin abnormalities19 have not been described. Further experimentation is
needed to elucidate the functions of the new members have been reported in TG mouse models expressing
KGF, TGF-a, and interferon g from epidermal-specificof this IL-10 family to more comprehensively understand
their similarities and differences. promoters (Vassar and Fuchs, 1991; Guo et al., 1993;
Carroll et al., 1997). No TG mouse model demonstratingTwo orphan class II cytokine receptors, both of which
are expressed in skin, were identified as IL-20 receptor all aspects of human psoriasis exists. For example, im-
mune infiltrates were not observed in the IL-20 TG mice.subunits. Both IL-20 receptor subunits are required for
ligand binding, distinguishing their role from that of sub- In addition, the ultrastructural features of the IL-20 TG
Cell
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Figure 7. In Situ Hybridization Demonstrates IL-20Ra and IL-20Rb mRNA Upregulation in Psoriasis
IL-20Ra mRNA expression is shown in (A), (C), (E), and (G), whereas IL-20Rb mRNA expression is shown in (B), (D), (F), and (H). Normal human
skin shows minimal to undetectable levels of both IL-20Ra and IL-20Rb mRNA (A and B). In contrast, increased staining for both receptor
subunits is observed in human psoriatic skin (C–H). Upregulation of both receptor subunit mRNAs is detected in keratinocytes (E and F), as
well as in endothelial and immune cells (G and H). Scale bar indicates: (A and B) 5 1 mm; (C and D) 5 2 mm; (E and F) 5 0.5 mm; and (G
and H) 5 0.2 mm.
mouse skin have been found in other hyperproliferative perplastic skin conditions in mice (Gijbels et al., 1995).
Finally, mottled keratohyaline granules were found indiseases of the epidermis. Decreased numbers of tono-
filaments, thought to be related to defective keratiniza- neonatal TGFa TG mice that had thickened skin due to
epidermal proliferation (Vassar and Fuchs, 1991). Wetion, are a striking feature of human psoriasis (Jahn et
al., 1988). Intramitochondrial inclusions have been found conclude that IL-20 TG mice appear to exhibit many of
the characteristics observed in human psoriasis.in both chemically induced and naturally occurring hy-
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indicating that the PAC contains part of the gene but is missing theA second line of evidence that implicates the IL-20
MDA-7 primer region.receptor in psoriasis is that both IL-20Ra and IL-20Rb
mRNA are markedly upregulated in human psoriatic skin
IL-20 Transgenic Micecompared to normal skin. Both IL-20 receptor subunits
Both human and mouse IL-20 cDNA coding sequences were ampli-
are expressed in keratinocytes throughout the epider- fied by PCR and cloned into plasmids containing different promot-
mis and are also expressed in a subset of immune and ers. Introns from rat insulin II, SV40 T-antigen, or human growth
endothelial cells. We propose that increased expression hormone were cloned either 59 or 39 of the IL-20 cDNA to improve
expression. Primers contained a consensus translation initiation siteof an activated IL-20 receptor may alter the interactions
upstream of the ATG. All plasmids used contain a 650 bp humanbetween endothelial cells, immune cells and keratino-
growth hormone (hGH) poly A sequence 39 of the coding sequence.cytes, leading to dysregulation of keratinocyte prolifera-
One half centimeter tail snips were isolated from pups (C57/Bl6
tion and differentiation. X C3H F2 hybrid mice) resulting from microinjection of the linearized
A crucial step in understanding the function of a novel expression cassette DNA. Genomic DNA was isolated using the
cytokine is the identification and characterization of its DNAeasy kit (Qiagen). Genotyping was performed by PCR using
three sets of primers against specific regions of the TG plasmids:cognate receptor. We have successfully used a struc-
hGH 39 UTR, flanking regions for the IL-20 cDNA insert, and anture-based approach to isolate a novel interleukin and
endogenous mouse gene.defined skin as a target tissue, which ultimately led to
Mouse tissues were dissected, stored in RNAlater (Ambion) and
the isolation of its receptor. We demonstrate that IL-20 total RNA was isolated using the RNAeasy kit (Qiagen). Expression
binds its receptor on keratinocytes and stimulates a analysis of IL-20 TG mRNA was performed using the Taqman RT-
STAT3-containing signal transduction pathway. The ef- PCR assay (Perkin Elmer) with primers against the hGH 39 UTR.
fect of IL-20 on skin differentiation in TG mice, together
Histological Analysiswith the upregulation of the IL-20 receptor subunits in
Tissues for light microscopy were collected in 10% neutral bufferedpsoriasis, pave the way for future studies on this ligand/
formalin, routinely processed, sectioned at 5 mm and stained withreceptor pair in inflammatory skin diseases.
hematoxylin and eosin. Skin sections for electron microscopy were
collected into paraformaldehyde-glutaraldehyde, routinely pro-
Experimental Procedures cessed, and stained with uranyl acetate (Sheehan and Hrapchak,
1980).
Bioinformatics Analysis
A novel “quasi-threading” algorithm, which inspects sequences for Immunohistochemistry for Epidermal Proteins
multiple profiles, was employed. Ungapped amino acid profiles of Carnoy’s fixed skin from the backs of normal and TG (newborn to
width n are two-dimensional matrices with dimensions n by 20 (Grib- day 3) mice were sectioned for immunohistochemistry. Polyclonal
skov et al., 1987). Profiles are used to provide the score for amino antibodies to mouse keratins 1, 5, 6, 10, and 14 as well as polyclonal
acids in each position of a polypeptide segment of length n. Trans- antibodies to mouse loricrin, involucrin and pro/filaggrin (Berkeley
lated EST and other DNA database sequences were threaded using Antibody Company) were followed by secondary biotinylated anti-
a protein structure–based profile linked by regions of variable length. rabbit IgG, amplified with immunoperoxidase (Vectastain ABC kit,
Two profiles of width 15, which described a signal sequence and Vector Laboratories), and visualized with diaminobenzidine as chro-
an amino-terminal amphipathic helix typical of helical cytokines with magen. PCNA immunohistochemistry was performed as described
a variable region from 1 to 30 residues, were used. by Dietrich (1993) on skin from TG mice expressing IL-20 from the
ALB and K14 promoters, and from their NTG littermates.
Cloning of Mouse IL-20
Recombinant IL-20Using a probe corresponding to the coding region of human IL-20,
IL-20 cDNA was generated by PCR and inserted into the pZP9NEEa mouse genomic lambda library (Clontech) was screened at low
mammalian expression vector containing the MT-1 promoter or thestringency, potential positives were identified and plaque purified
baculovirus expression vector pZBV3L (a modification of an In-to homogeneity, and subclones were generated for sequencing. The
vitrogen vector) containing the basic protein promoter. NEE is ansequence of one subclone revealed two predicted exons homolo-
N-terminal sequence tag with the sequence EYMPMEGS. Thegous to human IL-20. Oligonucleotides were designed to this se-
pZP9NEE-IL-20 vector was transfected into BHK570 cells by lipofec-quence and used for 59 and 39 RACE on mouse skin Marathon-
tamine and selected in DMEM 1 5% FBS with 1 mM methotrexate.ready cDNA, to generate the full-length coding sequence for mouse
Supernatants from resistant cells were analyzed for protein and highIL-20.
expressing clones were scaled up in cell factories. Protein was
purified from filtered BHK570 culture supernatants by EE mono-
Chromosomal Mapping of IL-20 clonal antibody affinity chromatography (Grussenmeyer et al., 1985).
IL-20 was mapped to chromosome 1 on both the lower resolution
GeneBridge 4 and the medium resolution Stanford G3 radiation
Receptor Binding Assays
hybrid (RH) mapping panels. Mouse IL-20 was mapped by PCR
A modification of the “secretion trap” (Davis et al., 1996) was per-
using the commercially available mouse T31 whole genome radia-
formed on COS7 cells transfected with candidate class II cytokine
tion hybrid (WGRH) panel (Research Genetics, Inc.) and IL-20 mu-
receptor cDNAs.
rine-specific sense and anti-sense primers. IL-10, IL-19, and MDA-7
were mapped by PCR using the commercially available version of the
Cell Culture and TransfectionsStanford G3 Human/Hamster RH panel (Research Genetics, Inc.).
HaCaT cells (Boukamp et al., 1988), were obtained from Dr. N. Fu-A PAC library and high-density array filters were obtained from
senig. BHK570 cells are deposited at ATCC (CRL-10314). StableRoswell Park Cancer Institute and were hybridized with probes from
BHK cell lines were generated by selection in puromycin (IL-20-Ra)the coding regions of human IL-19 and MDA-7. Four PAC clones
and zeocin (IL-20-Rb).were identified in this screen. Two additional clones (63B3 and 63H3)
were identified in a library from Genome Systems, using a PCR
screen with IL-10 primers. Inserts were sized using NotI digestion Binding Assays
Human IL-20 was iodinated using Iodobeads (Pierce). For competitionto excise inserts, followed by pulsed-field gel electrophoresis. To
determine gene order, PACs were analyzed using PCR (IL-19, binding assays, 250 pM 125I-IL-20 was used with or without 25 nM
competitor proteins. For saturation binding, a 30 nM to 13.7 pM dilutionMDA-7, and IL10) and hybridization (IL-20, MDA-7). PAC 141G11
was negative by PCR for MDA-7, but was positive by hybridization, series of 125I-IL-20 was used, with or without a 100-fold excess of
Cell
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unlabeled IL-20 for determination of specific binding. Scatchard analy- Acknowledgments
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